PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
血浆循环肿瘤DNA中的PIK3CA突变可预测晚期癌症患者的生存期和治疗结果。
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100230
Dumbrava, E E; Call, S G; Huang, H J; Stuckett, A L; Madwani, K; Adat, A; Hong, D S; Piha-Paul, S A; Subbiah, V; Karp, D D; Fu, S; Naing, A; Tsimberidou, A M; Moulder, S L; Koenig, K H; Barcenas, C H; Kee, B K; Fogelman, D R; Kopetz, E S; Meric-Bernstam, F; Janku, F
